FATE

Fate Therapeutics, Inc.

A San Diego biotech that grows "off-the-shelf" cell therapies for cancer and autoimmune disease. Using induced pluripotent stem cells — adult cells rewound to an early, flexible state — it programs batches of immune cells (natural killer and T cells) that can be stored and given to many patients, unlike therapies made from each person's own cells. Founded in 2007 by stem-cell scientists, the name comes from its mission to "direct the fate" of cells into specific immune fighters. Its ticker symbol on the stock market is fittingly FATE.

Recent Activity

Show $

2023Q1

3 sells

ARK Genomic Revolution ETFEXIT

-4.04M shares

ARK Genomic Revolution ETFEXIT

-4.04M shares

ARK Innovation ETFEXIT

-7.12M shares

ARK Innovation ETFEXIT

-7.12M shares

ARK InvestEXIT

-4.21M shares

ARK InvestEXIT

-4.21M shares

Loading more activity...